Experienced in Pneumonia

Dr. Joel A. Wirth

Pulmonary Medicine
100 Foden Road, West Building Suite 103, 
South Portland, ME 
Experienced in Pneumonia
100 Foden Road, West Building Suite 103, 
South Portland, ME 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joel Wirth is a Pulmonary Medicine provider in South Portland, Maine. Dr. Wirth is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cholesterol Pneumonia, and Lung Metastases.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pneumonia.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in ME
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

100 Foden Road, West Building Suite 103, South Portland, ME 04106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

7 Total Publications

Progressive Pericardial Effusions (PEF) in Patients With Pulmonary Arterial Hypertension (PAH) Taking Sotatercept-Association With Pre-Existing Pericardial Effusion.
Progressive Pericardial Effusions (PEF) in Patients With Pulmonary Arterial Hypertension (PAH) Taking Sotatercept-Association With Pre-Existing Pericardial Effusion.
Journal: Pulmonary circulation
Published: September 15, 2025
Similar Doctors
Advanced in Pneumonia
Dr. Jennifer Palminteri
Pulmonary Medicine
Advanced in Pneumonia
Dr. Jennifer Palminteri
Pulmonary Medicine

Chest Medicine Associates PA

100 Foden Rd Ste 103, 
South Portland, ME 
 (2.1 miles away)
207-828-1122
Languages Spoken:
English
See accepted insurances

Jennifer Palminteri is a Pulmonary Medicine provider in South Portland, Maine. Dr. Palminteri is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Cholesterol Pneumonia, and Lung Metastases.

Advanced in Pneumonia
Dr. Sanjay G. Godara
Intensive Care Medicine | Pulmonary Medicine | Sleep Medicine
Advanced in Pneumonia
Dr. Sanjay G. Godara
Intensive Care Medicine | Pulmonary Medicine | Sleep Medicine

Appledore Medical Group Inc

330 Borthwick Ave, Suite 108, 
Portsmouth, NH 
 (46.3 miles away)
603-436-4614
Languages Spoken:
English
See accepted insurances

Sanjay Godara is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Portsmouth, New Hampshire. Dr. Godara is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Emphysema.

Advanced in Pneumonia
Dr. Yasmin Mahal
Pulmonary Medicine
Advanced in Pneumonia
Dr. Yasmin Mahal
Pulmonary Medicine

Mainehealth

25 A June St, 
Sanford, ME 
 (25.6 miles away)
Languages Spoken:
English
See accepted insurances

Yasmin Mahal is a Pulmonary Medicine provider in Sanford, Maine. Dr. Mahal is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Endoscopy, and Pacemaker Implantation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wirth's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile